Weston, MA, United States of America

Simon C Robson

This inventor holds 4 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Beth Israel Deaconess Medical Center, Inc., Other. Active years: 2003-2026.

USPTO Granted Patents = 4 

% Patents Active = 25.0

 

Average Co-Inventor Count = 3.7

ph-index = 3

Forward Citations = 30(Granted Patents)


Company Filing History:


Years Active: 2003-2026

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Simon C Robson: Innovator in Therapeutic Applications

Introduction

Simon C Robson is a notable inventor based in Weston, MA (US). He has made significant contributions to the field of medicine, particularly in the treatment of inflammation and vascular disorders. With a total of 4 patents, his work has the potential to impact therapeutic practices significantly.

Latest Patents

Robson's latest patents include innovative methods for treating inflammation through the administration of heme oxygenase-1 and products derived from heme degradation. This invention focuses on utilizing heme oxygenase-1 to treat various disorders effectively. Another significant patent involves conjugates that comprise a biodegradable polymer linked to biologically active agents. These conjugates can be used therapeutically, particularly in treating and preventing thrombosis and vascular complications.

Career Highlights

Throughout his career, Simon C Robson has worked with reputable institutions, including Beth Israel Deaconess Medical Center, Inc. His research has led to advancements in understanding and treating complex medical conditions.

Collaborations

Robson has collaborated with esteemed colleagues such as David R Elmaleh and Mikhail L Papisov. These partnerships have contributed to the development of his innovative therapeutic approaches.

Conclusion

Simon C Robson's contributions to medical innovation highlight his role as a leading inventor in the field. His patents and collaborative efforts continue to pave the way for advancements in therapeutic applications.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…